Metabolic and Dietary Factors in Acne Vulgaris and Evaluation of the Acne Vulgaris Treatment with Oral Contraceptive-Based Therapies in Young Adult Women

Nutrients. 2023 Mar 20;15(6):1488. doi: 10.3390/nu15061488.

Abstract

The etiopathogenesis of acne is complex, as several endo- and exogenous factors that affect the sebaceous-hair unit are involved in the development of acne lesions. The main aim of the study was to evaluate selected metabolic parameters before treatment. Another goal of the study was to determine the correlation between selected metabolic and dietary parameters and the severity of acne before treatment. The third objective was to assess the severity of acne before and after treatment, considering the type of treatment used. The final objective was to assess the relationship between the difference in acne severity before and after treatment, considering the type of treatment used and factors of dairy or sweets intake. 168 women participated in the study. The patients belonged to two groups: the study group (99 patients with acne vulgaris) and the control group (69 patients without skin lesions). The study group was divided into subgroups according to the treatment used: contraceptive preparation, contraceptive preparation and cyproterone acetate, and contraceptive preparation and isotretinoin preparation. We found that LDL levels and consumption of sweets correlated with acne severity. The mainstay of acne treatment is contraceptive treatment (ethinylestradiol and drospirenone). The effectiveness of the three contraceptive-based treatments was confirmed by observing the severity of acne. There were no significant correlations between the difference in acne severity before and after treatment with the three treatments and factors of dairy or sweet consumption.

Keywords: acne; acne vulgaris; cholesterol; contraception; dairy; glucose; insulin; sweets; treatment; triglycerides.

MeSH terms

  • Acne Vulgaris* / drug therapy
  • Contraceptives, Oral*
  • Cyproterone Acetate
  • Ethinyl Estradiol
  • Female
  • Humans
  • Young Adult

Substances

  • Contraceptives, Oral
  • Ethinyl Estradiol
  • Cyproterone Acetate

Grants and funding

This research received no external funding.